Free/total prostate-specific antigen ratio can prevent unnecessary prostate biopsies - September 1 and 2, 1994

By Trinkler F.B.   Schmid D.M.   Hauri D.   Pei P.   Maly F.E.   Sulser T.  

Urology, Vol. 52, Iss. 3, 1998-09 ,pp. : 479-486

Elsevier

Access to resources Recommend Favorite

Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome

By Zagars G.K.   Pollack A.  

Urology, Vol. 45, Iss. 3, 1995-03 ,pp. : 476-483

Elsevier

Access to resources Recommend Favorite

Kinetics of postbiopsy levels of serum free prostate-specific antigen and percent free prostate-specific antigen - studies on the relative inhibition by alpha 2-macroglobulin and alpha 1-antichymotrypsin

By Lechevallier E.   Eghazarian C.   Ortega J.-C.   Daniel L.   Roux F.   Thirion X.   Coulange C.  

Urology, Vol. 53, Iss. 4, 1999-04 ,pp. : 731-735

Elsevier

Access to resources Recommend Favorite

Relationship of demographic and clinical factors to free and total prostate-specific antigen 1

By Gelmann E.P.   Chia D.   Pinsky P.F.   Andriole G.L.   Crawford E.D.   Reding D.   Hayes R.B.   Kramer B.S.   Woodrum D.L.   Gohagan J.K.   Levin D.L.   For the PLCO Screening Trial Investigators  

Urology, Vol. 58, Iss. 4, 2001-10 ,pp. : 561-566

Elsevier

Access to resources Recommend Favorite

Disappearance of well-differentiated carcinoma of the prostate: effect of transurethral resection of the prostate, prostate-specific antigen, and prostate biopsy 1

By Endrizzi J.   Optenberg S.   Byers R.   Thompson I.M.  

Urology, Vol. 57, Iss. 4, 2001-04 ,pp. : 733-736

Elsevier

Access to resources Recommend Favorite